Tokyo-Based LTT Bio-Pharma Names New President
This article was originally published in PharmAsia News
Executive Summary
Japanese regenerative medicine company, Tokyo-based LTT Bio-Pharma names Iwao Suzuki as its new president, effective June 25. Current president Toshimi Nishiyama becomes the board director. Suzuki joined LTT in March as director of operations and the appointment came as a surprise to many. Several executives recently resigned following an investment scandal involving a LTT subsidiary. LTT's founder Yutaka Mizushima also died recently. (Click here for more - Japanese language